• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转录组学荟萃分析确定了在含有遗传性PMS2错配修复缺陷的结直肠癌肿瘤中凝血和纤维蛋白溶解途径上调。

Transcriptomic Meta-Analysis Identifies Upregulated Clotting and Fibrinolysis Pathways in Colorectal Cancer Tumors Containing Hereditary PMS2 Mismatch Repair Deficiency.

作者信息

Gibson Trenton M, Spendlove Mauri D, Rapier-Sharman Naomi, Pickett Brett E

机构信息

Microbiology and Molecular Biology, Brigham Young University, Provo, Utah, United States.

Microbiology and Molecular Biology, Brigham Young University.

出版信息

MicroPubl Biol. 2024 Jul 27;2024. doi: 10.17912/micropub.biology.001159. eCollection 2024.

DOI:10.17912/micropub.biology.001159
PMID:39139583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11320117/
Abstract

Lynch Syndrome is characterized by deficient mismatch repair (dMMR) components. We performed a meta-analysis of multiple RNA-sequencing datasets from patients with different dMMR variants (PMS2, MLH1, and MSH2) to better characterize the unique transcriptional profiles. Our results reveal enriched signaling pathways from tumor samples with germline mutations in the PMS2 gene including upregulation in pathways related to intrinsic and extrinsic prothrombin activation, fibrinolysis, and uPA/uPAR-mediated signaling. These pathways have been associated with tumor growth, invasiveness, and metastasis. This work provides support for further exploration into the role of PMS2 in tumor development, and as a potential therapeutic mechanism.

摘要

林奇综合征的特征是错配修复缺陷(dMMR)成分。我们对来自不同dMMR变异(PMS2、MLH1和MSH2)患者的多个RNA测序数据集进行了荟萃分析,以更好地描述独特的转录谱。我们的结果揭示了PMS2基因发生种系突变的肿瘤样本中富集的信号通路,包括与内源性和外源性凝血酶原激活、纤维蛋白溶解以及uPA/uPAR介导的信号传导相关的通路上调。这些通路与肿瘤生长、侵袭和转移有关。这项工作为进一步探索PMS2在肿瘤发展中的作用以及作为一种潜在的治疗机制提供了支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/585d/11320117/dbdc7650b6f3/25789430-2024-micropub.biology.001159.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/585d/11320117/dbdc7650b6f3/25789430-2024-micropub.biology.001159.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/585d/11320117/dbdc7650b6f3/25789430-2024-micropub.biology.001159.jpg

相似文献

1
Transcriptomic Meta-Analysis Identifies Upregulated Clotting and Fibrinolysis Pathways in Colorectal Cancer Tumors Containing Hereditary PMS2 Mismatch Repair Deficiency.转录组学荟萃分析确定了在含有遗传性PMS2错配修复缺陷的结直肠癌肿瘤中凝血和纤维蛋白溶解途径上调。
MicroPubl Biol. 2024 Jul 27;2024. doi: 10.17912/micropub.biology.001159. eCollection 2024.
2
Risk of secondary malignancy (including breast) in patients with mismatch-repair protein deficiency.错配修复蛋白缺陷患者的继发性恶性肿瘤(包括乳腺癌)风险。
Am J Surg Pathol. 2014 Nov;38(11):1494-500. doi: 10.1097/PAS.0000000000000259.
3
Molecular Background of Colorectal Tumors From Patients With Lynch Syndrome Associated With Germline Variants in PMS2.林奇综合征相关种系变异 PMS2 患者结直肠肿瘤的分子背景。
Gastroenterology. 2018 Sep;155(3):844-851. doi: 10.1053/j.gastro.2018.05.020. Epub 2018 Jul 29.
4
Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome.斯洛文尼亚结直肠癌患者种系 MLH1、MSH2、MSH6 和 PMS2 基因突变的筛查:对林奇综合征人群特异性检测策略的影响。
Fam Cancer. 2009;8(4):421-9. doi: 10.1007/s10689-009-9258-4. Epub 2009 Jun 13.
5
Characteristics of Mismatch Repair-Deficient Colon Cancer in Relation to Mismatch Repair Protein Loss, Hypermethylation Silencing, and Constitutional and Biallelic Somatic Mismatch Repair Gene Pathogenic Variants.错配修复缺陷型结直肠癌的特征与错配修复蛋白缺失、高甲基化沉默以及胚系和双等位基因体细胞错配修复基因致病性变异有关。
Dis Colon Rectum. 2023 Apr 1;66(4):549-558. doi: 10.1097/DCR.0000000000002452. Epub 2022 Jun 20.
6
Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome.九种不同肿瘤中错配修复缺陷情况的发生率和分子特征,以及涉及林奇样综合征的种系变异体的鉴定。
Int J Clin Oncol. 2024 Jul;29(7):953-963. doi: 10.1007/s10147-024-02518-y. Epub 2024 Apr 14.
7
Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations.错配修复缺陷的结肠癌和子宫内膜癌可能源于体细胞突变,而非种系突变。
Gastroenterology. 2014 Dec;147(6):1308-1316.e1. doi: 10.1053/j.gastro.2014.08.041. Epub 2014 Sep 3.
8
Germline MLH1 Mutations Are Frequently Identified in Lynch Syndrome Patients With Colorectal and Endometrial Carcinoma Demonstrating Isolated Loss of PMS2 Immunohistochemical Expression.在林奇综合征患者中,结直肠癌和子宫内膜癌患者若显示PMS2免疫组化表达单独缺失,则常可检测到胚系MLH1突变。
Am J Surg Pathol. 2015 Aug;39(8):1114-20. doi: 10.1097/PAS.0000000000000425.
9
Double somatic mismatch repair gene pathogenic variants as common as Lynch syndrome among endometrial cancer patients.子宫内膜癌患者中双体种系错配修复基因突变与林奇综合征一样常见。
Gynecol Oncol. 2021 Jan;160(1):161-168. doi: 10.1016/j.ygyno.2020.10.012. Epub 2020 Oct 21.
10
Potential predictors for CDX2 expression loss and mismatch repair deficiency in colorectal cancer.结直肠癌中 CDX2 表达缺失和错配修复缺陷的潜在预测因子。
Pathol Oncol Res. 2023 May 31;29:1610908. doi: 10.3389/pore.2023.1610908. eCollection 2023.

本文引用的文献

1
Pathway2Targets: an open-source pathway-based approach to repurpose therapeutic drugs and prioritize human targets.Pathway2Targets:一种基于开源途径的药物重定位方法,可优先考虑人类靶点。
PeerJ. 2023 Sep 29;11:e16088. doi: 10.7717/peerj.16088. eCollection 2023.
2
Lynch syndrome, molecular mechanisms and variant classification.林奇综合征的分子机制和变异分类。
Br J Cancer. 2023 Mar;128(5):726-734. doi: 10.1038/s41416-022-02059-z. Epub 2022 Nov 24.
3
Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer.
尿激酶型纤溶酶原激活物受体(uPAR)作为癌症的治疗靶点。
J Transl Med. 2022 Mar 18;20(1):135. doi: 10.1186/s12967-022-03329-3.
4
UALCAN: An update to the integrated cancer data analysis platform.UALCAN:一个集成癌症数据分析平台的更新。
Neoplasia. 2022 Mar;25:18-27. doi: 10.1016/j.neo.2022.01.001. Epub 2022 Jan 22.
5
Mismatch repair deficiency: The what, how and why it is important.错配修复缺陷:是什么、如何以及为什么重要。
Genes Chromosomes Cancer. 2022 Jun;61(6):314-321. doi: 10.1002/gcc.23015. Epub 2021 Dec 9.
6
Fibrinolytic System and Cancer: Diagnostic and Therapeutic Applications.纤维蛋白溶解系统与癌症:诊断与治疗应用。
Int J Mol Sci. 2021 Apr 22;22(9):4358. doi: 10.3390/ijms22094358.
7
Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumors.1057 例微卫星不稳定高固体肿瘤中 MLH1、PMS2、MSH2 和 MSH6 基因特异性改变与肿瘤突变负担的关系。
Int J Cancer. 2020 Nov 15;147(10):2948-2956. doi: 10.1002/ijc.33115. Epub 2020 Jun 18.
8
ARMOR: An utomated eproducible dular Workflow for Preprocessing and Differential Analysis of NA-seq Data.ARMOR:一种用于预处理和差异分析 NA-seq 数据的自动化可重复模块化工作流程。
G3 (Bethesda). 2019 Jul 9;9(7):2089-2096. doi: 10.1534/g3.119.400185. Print 2019 Jul 1.
9
Clinical significance of plasma D-dimer and fibrinogen in digestive cancer: A systematic review and meta-analysis.血浆 D-二聚体和纤维蛋白原在消化道癌中的临床意义:系统评价和荟萃分析。
Eur J Surg Oncol. 2018 Oct;44(10):1494-1503. doi: 10.1016/j.ejso.2018.07.052. Epub 2018 Jul 31.
10
The Reactome Pathway Knowledgebase.Reactome 通路知识库。
Nucleic Acids Res. 2018 Jan 4;46(D1):D649-D655. doi: 10.1093/nar/gkx1132.